Header Logo

Connection

RAJYALAKSHMI LUTHRA to Pyridines

Back to Details
This is a "connection" page, showing publications RAJYALAKSHMI LUTHRA has written about Pyridines.
RAJYALAKSHMI LUTHRA
Connection Strength
0.013
Pyridines
  1. Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia. J Clin Oncol. 2010 Apr 10; 28(11):1856-62.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.